Zois Syrgiannis, PhD
Co-Founder & Chief Executive Officer, NanoNeurosciences Inc.
Dr. Zois Syrgiannis is the CEO and Co-Founder of NanoNeurosciences Inc., a biotechnology startup developing advanced nanomedicine platforms for the treatment of neurological and ophthalmological disorders. With a scientific background in organic chemistry, nanotechnology, peptide chemistry, and drug delivery systems, he brings over twenty years of research and translational experience to the biotech space. Zois is passionate about bridging cutting-edge science with real-world clinical solutions and is currently leading efforts to move NanoNeurosciences’ lead candidate into IND-enabling studies. He has authored multiple peer-reviewed publications and has been involved in international collaborations in both academic and industry settings. Committed to innovation with impact, he is expanding the company’s technology into adjacent fields such as cosmetics and defense health. He holds a PhD in Chemistry and has been actively involved in biotech innovation ecosystems in the U.S. and Europe.